Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions David Burrows
Elan Corp.ELNDON'T BUYFeb 15, 2002
Questionable accounting practices.
David BurrowsUnknown
$13.68
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
BUY
Pet adoption enjoyed a boom during the Covid lockdown. Shares have more than doubled since last year's bottom, including jumping 6% today after an excellent quarterly report. Plus, ELN is getting a boost from rising food prices. Today, they announced a blowout quarter with higher than expected earnings and sales and raised full-year guidance.
biotechnologypharmaceutical
DON'T BUY
DON'T BUY
